Daily briefing: Narcolepsy drug could kick off an Ozempic-style moment for the brain

TL;DR - Nature’s daily briefing highlights orexin agonists as promising treatments for narcolepsy and potentially other brain disorders, drawing a broad comparison with the impact of GLP-1 drugs.

• Orexin agonists target signaling involved in wakefulness.
• The supplied excerpt does not provide trial data, efficacy results, or safety findings.
• The briefing also mentions Argentine postdoc protests and a record-resolution image of the Sun’s photosphere.